Annual Total Assets
$20.99 M
-$12.37 M-37.08%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total assets is $20.99 million, with the most recent change of -$12.37 million (-37.08%) on December 31, 2023.
- During the last 3 years, AVTX annual total assets has fallen by -$22.76 million (-52.02%).
- AVTX annual total assets is now -73.83% below its all-time high of $80.21 million, reached on December 31, 2021.
Performance
AVTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$98.45 M
-$9.85 M-9.10%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total assets is $98.45 million, with the most recent change of -$9.85 million (-9.10%) on September 30, 2024.
- Over the past year, AVTX quarterly total assets has dropped by -$9.85 million (-9.10%).
- AVTX quarterly total assets is now -20.43% below its all-time high of $123.73 million, reached on March 31, 2024.
Performance
AVTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
AVTX Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -37.1% | -9.1% |
3 y3 years | -52.0% | +195.1% |
5 y5 years | -70.1% | +72.1% |
AVTX Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -73.8% | at low | -20.4% | +369.0% |
5 y | 5-year | -73.8% | at low | -20.4% | +369.0% |
alltime | all time | -73.8% | +313.6% | -20.4% | +2665.0% |
Avalo Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $98.45 M(-9.1%) |
Jun 2024 | - | $108.31 M(-12.5%) |
Mar 2024 | - | $123.73 M(+489.4%) |
Dec 2023 | $20.99 M(-37.1%) | $20.99 M(-28.3%) |
Sep 2023 | - | $29.27 M(+20.8%) |
Jun 2023 | - | $24.23 M(-33.1%) |
Mar 2023 | - | $36.23 M(+8.6%) |
Dec 2022 | $33.37 M(-58.4%) | $33.37 M(-8.7%) |
Sep 2022 | - | $36.55 M(+13.4%) |
Jun 2022 | - | $32.22 M(-47.9%) |
Mar 2022 | - | $61.90 M(-22.8%) |
Dec 2021 | $80.21 M(+83.3%) | $80.21 M(-15.9%) |
Sep 2021 | - | $95.36 M(+48.8%) |
Jun 2021 | - | $64.08 M(+1.2%) |
Mar 2021 | - | $63.34 M(+44.8%) |
Dec 2020 | $43.76 M(+21.2%) | $43.76 M(-26.1%) |
Sep 2020 | - | $59.19 M(-14.5%) |
Jun 2020 | - | $69.20 M(+56.9%) |
Mar 2020 | - | $44.12 M(+22.2%) |
Dec 2019 | $36.11 M | $36.11 M(-36.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $57.19 M(-4.1%) |
Jun 2019 | - | $59.62 M(-20.4%) |
Mar 2019 | - | $74.87 M(+6.6%) |
Dec 2018 | $70.25 M(+64.1%) | $70.25 M(+3.9%) |
Sep 2018 | - | $67.61 M(+8.8%) |
Jun 2018 | - | $62.15 M(-4.9%) |
Mar 2018 | - | $65.36 M(+52.7%) |
Dec 2017 | $42.81 M(+642.0%) | $42.81 M(+51.8%) |
Sep 2017 | - | $28.20 M(+366.4%) |
Jun 2017 | - | $6.05 M(+69.8%) |
Mar 2017 | - | $3.56 M(-38.3%) |
Dec 2016 | $5.77 M(-73.4%) | $5.77 M(-39.8%) |
Sep 2016 | - | $9.58 M(-27.2%) |
Jun 2016 | - | $13.17 M(-22.2%) |
Mar 2016 | - | $16.93 M(-21.8%) |
Dec 2015 | $21.66 M(+75.8%) | $21.66 M(+297.3%) |
Sep 2015 | - | $5.45 M(-28.1%) |
Jun 2015 | - | $7.58 M(-17.3%) |
Mar 2015 | - | $9.17 M(-25.6%) |
Dec 2014 | $12.32 M(+142.7%) | $12.32 M |
Dec 2013 | $5.08 M | - |
FAQ
- What is Avalo Therapeutics annual total assets?
- What is the all time high annual total assets for Avalo Therapeutics?
- What is Avalo Therapeutics annual total assets year-on-year change?
- What is Avalo Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly total assets year-on-year change?
What is Avalo Therapeutics annual total assets?
The current annual total assets of AVTX is $20.99 M
What is the all time high annual total assets for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total assets is $80.21 M
What is Avalo Therapeutics annual total assets year-on-year change?
Over the past year, AVTX annual total assets has changed by -$12.37 M (-37.08%)
What is Avalo Therapeutics quarterly total assets?
The current quarterly total assets of AVTX is $98.45 M
What is the all time high quarterly total assets for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total assets is $123.73 M
What is Avalo Therapeutics quarterly total assets year-on-year change?
Over the past year, AVTX quarterly total assets has changed by -$9.85 M (-9.10%)